Founded in 1989, OrbiMed is a private equity and hedge fund manager based in New York, New York. The firm invests in the pharmaceutical, life science, healthcare service, medical device, biopharmaceutical, and diagnostic sectors. The firm invests in U.S. and non-U.S. equities, both long and short and event-driven, as well as privately placed securities, debt securities, royalty bonds, and other royalty instruments, currencies, private investments in public equity securities, ETFs, index options, and derivatives.